CBI 7206
No. of Pages 9, Model 5G
9 December 2014
8
L.F. Pires et al. / Chemico-Biological Interactions xxx (2014) xxx–xxx
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
It has been published that glutamate, aspartate and glutamine
578
References
levels are increased during seizures [46,47], instead the results
obtained in this study were different, showing no increase in these
amino acid levels in seizures induced by P400, PTZ and PIC when
compared with negative control.
However, it seems there is not a complete consensus about
these amino-acid levels in epilepsy models. On studying frontal
and temporal foci, Van Gelder and co-workers found a decrease
in aspartate in all the examined areas, and a decrease in glutamate
levels in excitable regions [48]. Conversely, another study reported
a 28% increase in aspartate concentration in surgical specimens
from patients with temporal epilepsy [48,49].
Nevertheless, there are a greater number of studies showing the
tendency of animal in epilepsy models suffer an increase in GABA
levels when treated with anticonvulsant agents, which is in accor-
dance with our results [46–50].
The addition of an ester group to carvacrol theoretically could
confer CA an additional lipophilic property, which would allow
an easier penetration on blood–brain barrier and exerts its possible
therapeutic potential more safely and effectively. However, there
are not any study comparing these parameters between carvacrol
and CA [51]. Additionally, it is not possible to compare anticonvul-
sant activity of CA with carvacrol yet, since the CA doses used in
our experiment were different from carvacrol doses used by Quin-
tans-Júnior et al., 2010 [10].
This study showed significant anticonvulsant effects of CA at
dose 100 mg/kg. Beyond this anticonvulsant effect, CA improved
Na+, K+-ATPase and d-ALA-D enzymatic activities. These findings
can be correlated with the antioxidant effect suggested previously,
in which CA at different concentrations and doses tested, including
at dose 100 mg/kg, reduced lipid peroxidation content and nitrite
levels (in vitro and in vivo) and hydroxyl radical formation
in vitro, as well as increased reduced glutathione levels and
improved glutathione peroxidase and catalase activities in vivo
[17]. Taken all these findings together, CA could suggest multifac-
torial action mechanisms that can contribute to their anticonvul-
sant effects.
[1] M. Wong, Advances in the pathophysiology of developmental epilepsies, Semin. Q4 579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
Pediatr. Neurol. 12 (2005) 72–78.
[2] M.J. Brodie, Diagnosing and predicting refractory epilepsy, Acta Neurol. Scand.
Suppl. 181 (2005) 36–39.
[3] W. Loscher, D. Schmidt, Experimental and clinical evidence for loss of effect
(tolerance) during prolonged treatment with antiepileptic drugs, Epilepsia 47
(2006) 1253–1284.
[4] J.P. Costa, P.B. Ferreira, D.P. Sousa, J. Jordán, R.M. Freitas, Anticonvulsant effect of
phytol in a pilocarpine model in mice, Neurosci. Lett. 523 (2012) 115–118.
[5] J.S. Costa Júnior, C.M. Feitosa, A.M.G.L. Citó, R.M. Freitas, J.A.P. Henriques, J. Saffi,
Evaluation of effects of ethanolic extract (EE) from Platonia insignis Mart. on
pilocarpine-induced seizures, J. Biol. Sci. 10 (2010) 747–753.
[6] G.M. Khan, I. Smolders, G. Ebinger, Y. Michotte, 2-Chloro-N6-
cyclopentyladenosine-elicited attenuation of evoked glutamate release is not
sufficient to give complete protection against pilocarpine-induced seizures in
rats, Neuropharmacology 40 (2001) 657–667.
[7] F.O. Silva, G.S. Cerqueira, E.B. Sabino, C.M. Feitosa, R.M. Freitas, Central nervous
system effects of Iso-6-spectaline isolated from Senna spectabilis var. excelsa
(schrad) in mice, J. Young Pharm. 3 (2011) 232–236.
[8] T. Kádár, A. Pesti, B. Penke, G. Tóth, M. Zarándi, G. Telegdy, Structure–activity
and dose–effect relationships of the antagonism of picrotoxin-induced seizures
by cholecystokinin, fragments and analogues of cholecystokinin in mice,
Neuropharmarcology 22 (1983) 1223–1229.
[9] F.A.O. Silva, M.G.V. Silva, D. Feng, R.M. Freitas, Evaluation of central nervous
system effects of iso-6-cassine isolated from Senna spectabilis var. excels
(Schrad) in mice, Fitoterapia 82 (2011) 255–259.
[10] L.J. Quintans-Júnior, A.G. Guimarães, B.E.S. Araújo, G.F. Oliveira, M.T. Santana,
F.V. Moreira, M.R.V. Santos, S.C.H. Cavalcanti, W. De Lucca Jr., M.A. Botelho,
L.A.A. Ribeiro, F.F.F. Nóbrega, R.N. Almeida, Carvacrol, (À)-borneol and citral
reduce convulsant activity in rodents, Afr. J. Biotechnol. 9 (2010) 6566–6572.
[11] L.F. Pires, L.M. Costa, O.A. Silva, A.A.C. Almeida, G.S. Cerqueira, D.P. de Sousa,
R.M. Freitas, Anxiolytic-like effects of carvacryl acetate,
a derivative of
carvacrol, in mice, Pharmacol. Biochem. Behav. 112 (2013) 42–48.
[12] R.M. Freitas, Lipoic acid alters d-aminolevulinic dehydratase, glutathione
peroxidase and Na+, K+-ATPase activities and glutathione reduced levels in rat
hippocampus after pilocarpine induced seizures, Cell. Mol. Neurobiol. 30
(2010) 381–387.
[13] R.M. Freitas, D. Feng, J. Jordán, Neuropharmacological effects of lipoic acid and
ubiquinone on d-aminolevulinic dehydratase, Na+, K+-ATPase, and Mg2+-
ATPase activities in rat hippocampus after pilocarpine induced seizures,
Fundam. Clin. Pharmacol. 25 (2010) 211–216.
[14] G.F. Souza, G.B. Saldanha, R.M. Freitas, Lipoic acid increases glutathione
peroxidase, Na+, K+-ATPase and acetylcholinesterase activities in rat
hippocampus after pilocarpine-induced seizures?, Arq Neuropsiquiatr. 68
(2010) 586–591.
[15] R.M. Freitas, L. Aguiar, S.M.M. Vasconcelos, F.C.F. Sousa, G.S.B. Viana, M.M.F.
Fonteles, Modifications in muscarinic, dopaminergic and serotonergic
receptors concentrations in the hippocampus and striatum of epileptic rats,
Life Sci. 78 (2005) 253–258.
[16] I.M.S. Santos, A.R. Tomé, C.M. Feitosa, G.F. Souza, D. Feng, R.M. Freitas, J. Jordán,
Lipoic acid blocks seizures induced by pilocarpine via increases in d-
aminolevulinic dehydratase and Na+, K+-ATPase activity in rat brain,
Pharmacol. Biochem. Behav. 95 (2010) 88–91.
[17] L.F. Pires, L.M. Costa, O.A. Silva, A.A.C. Almeida, G.S. Cerqueira, D.P. de Sousa,
R.M. Freitas, Is there a correlation between in vitro antioxidant potential and
in vivo effect of carvacryl acetate against oxidative stress in mice
hippocampus?, Neurochem Res. 39 (2014) 758–769.
[18] A.A. Oliveira, F.C.F. Sousa, S.M.M. Vasconcelos, G.S.B.F. Viana, M.M.F. Fonteles,
R.M. Freitas, Pathophysiology of status epilepticus induced by pilocarpine,
Cent. Nerv. Syst. Agents Med. Chem. 7 (2007) 11–15.
[19] I.M.S. Santos, A.R. Tomé, G.B. Saldanha, P.M.P. Ferreira, G.C.G. Militão, R.M.
Freitas, Oxidative stress in the hippocampus during experimental seizures can
be ameliorated with the antioxidant ascorbic acid, Oxid. Med. Cell. Longev. 2
(2009) 1–8.
560
5. Conclusions
561
Although the anticonvulsant activity of CA was not superior to
diazepam in this study, but CA did not alter locomotor activity
and suggested that improve Na+, K+-ATPase and d-aminolevulinic
acid dehydratase activities. Some amino acid concentrations in
mice hippocampus after seizures induced by P400, PTZ or PIC,
which were altered by seizures, were also regulated after CA treat-
ment. In summary, CA anticonvulsant property seems to be multi-
factorial, demonstrating a significant potential in epilepsy models.
562
563
564
565
566
567
568 Q2
569
570
Conflict of Interest
[20] A.I. Vogel, A.R. Tatchell, B.S. Furnis, Vogel’s Textbook of Practical Organic
Chemistry, fifth ed., Prentice Hall, 1996.
[21] M. Smith, K.S. Wilcox, H.S. White, Discovery of antiepileptic drugs,
Neurotherapeutics 4 (2007) 12–17.
[22] S.R.B. Damasceno, F.R.A.M. Oliveira, N.S. Carvalho, C.F.C. Brito, I.S. Silva, F.B.M.
Sousa, R.O. Silva, D.P. Sousa, A.L.R. Barbosa, R.M. Freitas, J.R. Medeiros,
The author states no conflict of interest.
571
Uncited references
Carvacryl acetate,
a derivative of carvacrol, reduces nociceptive and
inflammatory response in mice, Life Sci. 94 (2014) 58–66.
[23] R.M. Freitas, S.M.M. Vasconcelos, F.C.F. Souza, G.S.B. Viana, M.M.F. Fonteles,
Monoamine levels after pilocarpine-induced status epilepticus in
hippocampus and frontal cortex of Wistar rats, Neurosci. Lett. 370 (2004)
196–200.
[24] R.M. Freitas, C.F.B. Felipe, V.S. Nascimento, A.A. Oliveira, G.S.B. Viana, M.M.F.
Fonteles, Pilocarpine-induced seizures in adult rats: monoamine content and
muscarinic and dopaminergic receptor changes in the striatum, Comp.
Biochem. Physiol. Part C 160 (2003) 103–108.
572 Q3
[12,13,16].
573
Acknowledgments
574
575
576
577
We would like to thank the National Council of Technological
and Scientific Development (CNPq/Brazil) and the Research Sup-
porting Foundation of State of Piaui (FAPEPI/Brazil) for the financial
support and Stênio Gardel Maia for technical assistance.
[25] J. Lehmann, A. Hutchison, S.E. McPherson, C. Mondadori, M. Schmutz, C.M.
Sinton, C. Tsai, D.E. Murphy, D.J. Steel, M. Williams, D.L. Cheney, P.L. Wood, CGS
Please cite this article in press as: L.F. Pires et al., Neuropharmacological effects of carvacryl acetate on d-aminolevulinic dehydratase, Na+, K+-ATPase activ-